Citius Pharmaceuticals Inc (CTXR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,786 | -9,225 | -23,054 | -18,093 | -12,269 |
| Depreciation Amortization | 88 | 44 | 165 | 122 | 80 |
| Accounts payable and accrued liabilities | 428 | 512 | -579 | -502 | -723 |
| Other Working Capital | 182 | 3,530 | -2,717 | -1,749 | -2,335 |
| Other Operating Activity | 1,772 | 488 | 1,936 | 1,563 | 1,411 |
| Operating Cash Flow | $-14,317 | $-4,652 | $-24,250 | $-18,659 | $-13,836 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -7 | -7 | N/A |
| Other Investing Activity | 0 | 0 | -40,000 | 0 | 0 |
| Investing Cash Flow | $N/A | $N/A | $-40,007 | $-7 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | 102,193 | 102,193 | 85,223 |
| Other Financing Activity | 0 | 0 | 18,278 | 18,278 | 18,450 |
| Financing Cash Flow | $0 | $N/A | $120,471 | $120,471 | $103,673 |
| Beginning Cash Position | 70,073 | 70,073 | 13,860 | 13,860 | 13,860 |
| End Cash Position | 55,756 | 65,421 | 70,073 | 115,664 | 103,697 |
| Net Cash Flow | $-14,317 | $-4,652 | $56,213 | $101,804 | $89,837 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,317 | -4,652 | -24,250 | -18,659 | -13,836 |
| Capital Expenditure | N/A | N/A | -7 | -7 | N/A |
| Free Cash Flow | -14,317 | -4,652 | -24,257 | -18,666 | -13,836 |